Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cognitive functioning in a cohort of high-grade glioma patients.

Radiology and oncology - 1 Jun 2023

Skufca Smrdel Andreja Cirila, Podlesek Anja, Skoblar Vidmar Marija, Markovic Jana, Jereb Jana, Okorn Manja Kuzma, Smrdel Uros

Abstract excerpt

BACKGROUND: High grade gliomas are associated with cognitive problems. The aim of the study was to investigate cognitive functioning in a cohort of patients with high grade glioma, according to isocitrate dehydrogenase (IDH) and methyl guanine methyl transferase (MGMT) status and other clinical characteristics. PATIENTS AND METHODS: The patients with the high-grade glioma treated in Slovenia in given period of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cognition
Share to Cohort Studies
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 37341199
DOI: 10.2478/raon-2023-0009
PMCID: PMC10286884

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cognitive functioning in a cohort of high-grade glioma patients.PMID 37341199Read ↗

Cognitive functioning is prognostic in patients with IDH1-wild type and MGMT-unmethylated high-grade gliomas.Semantic proximity Read ↗

Isocitrate Dehydrogenase, Patient-Reported Outcomes, and Cognitive Functioning of Glioma Patients: a Systematic Review.Semantic proximity Read ↗

Reliable cognitive changes the first year following guideline-based treatment of isocitrate dehydrogenase mutated gliomas: A longitudinal multicenter study.Semantic proximity Read ↗

BDNF, COMT, and DRD2 polymorphisms and ability to return to work in adult patients with low- and high-grade gliomaSemantic proximity Read ↗

Cognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy.Semantic proximity Read ↗

Genetic Modulation of Neurocognitive Function in Glioma Patients.Semantic proximity Read ↗

Assessing cognitive function in cancer patients after chemotherapySemantic proximity Read ↗

The APOE ε4 allele in relation to pre- and postsurgical cognitive functioning of patients with primary brain tumors.Semantic proximity Read ↗

Neurocognitive functioning and genetic variation in patients with primary brain tumours.Semantic proximity Read ↗

Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force.Semantic proximity Read ↗

Impact of APOE Genotype on Neurocognition Following Conformal Whole Brain Radiotherapy for Brain Metastases: A Post hoc Analysis of Phase II Randomized TrialSemantic proximity Read ↗

Multidimensional preoperative cognitive phenotypes predict postoperative cognition in glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.